Based on all of these findings, we set out to investigate whether CHD5 single-nucleotide polymorphisms (SNPs) were associated with risk of Alzheimer's disease in a two-stage case-control study from China. This evidence concerns the gene CHD5 and early-onset autosomal dominant Alzheimer disease.